Oramed

1 stories about Oramed
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18|CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1